Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB08951ApprovedWithdrawnSmall molecule
A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide.
- Mechanism
- Curator reviewed
Pharmacologically active on Human Cyclooxygenases
- Formula / weight
- C17H15NO3 · 281.3059 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
RJMIEHBSYVWVIN-UHFFFAOYSA-NSMILESCC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=OWhat you can answer from here — as of June 15, 2026
7Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Indoprofen, and which of those have an active Phase 3 trial?